We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026

$29 Billion In Vitro Diagnostics Market Seen for 2007

By HospiMedica staff writers
Posted on 13 Feb 2002
The in vitro diagnostics (IVD) market generated revenues of nearly US$20 billion in 2000 and is projected to surge to more than $29 billion by 2007, according to a new analysis from Frost & Sullivan entitled "World In Vitro Diagnostic Technologies Markets.”

In vitro diagnostics offer early, accurate diagnosis of diseases, but a lack of comprehensive laboratory automation has slowed the evolution of absolute efficiency, according to Frost and Sullivan's analysis. More...
While automation has made important progress in recent years, there is a strong, often-overlooked need for automation in laboratory specimen processing, prioritizing, and preparation. The workload in this part of the IVD system is often erratic, making it a difficult section to automate. As a result, operations may slow down and experience delays that interrupt the smooth flow necessary for overall efficiency. Eventually, this results in a bottleneck within the processing section, and this constriction may cause inefficiency within other parts of the IVD procedures.

"In order to improve laboratory efficiency, efforts should be made to develop at least a partially automated system for the processing section,” said Frost & Sullivan analyst Kelly Westfall. "Until a reliable system can be integrated in processing, facilities will not fully realize how effectively their current automated workstations are operating.”




Related Links:
Frost & Sullivan

Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
POC Immunoassay Analyzer
Procise DX
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.